IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

Barlesi, F. ; Nishio, M. ; Cobo, M. ; Steele, N. ; Paramonov, V. ; Parente, B. ; Dear, R. ; Berard, H. ; Peled, N. ; Seneviratne, L.C. ; Baldini, E. ; Watanabe, S. ; Goto, K. ; Mendus, D. ; Patel, H. ; Deng, Y. ; Kowanetz, M. ; Hoang, T. ; Lin, W. ; Papadimitrakopoulou, V.A.

Annals of oncology, 2018-10, Vol.29, p.viii743-viii744 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível